King & Spalding·REGULATORY / GOVERNMENT

HHS, DOJ Kick Off Healthcare False Claims Self‑Disclosure Pilot

The federal government rolls out a six‑month pilot giving healthcare firms a chance to self‑disclose alleged false claims and potentially avoid penalties.

The U.S. Department of Health and Human Services (HHS) and the Department of Justice (DOJ) Civil Division announced on October 22, 2026 the launch of a new Healthcare False Claims Act Self‑Disclosure Pilot Program (FCA SDPP). The six‑month initiative allows qualified healthcare companies to voluntarily submit information about potentially false claims before any formal investigation or lawsuit. In exchange for credible, timely disclosure, participants may receive more favorable treatment—such as reduced penalties, expedited resolution, and the opportunity to negotiate settlements. The pilot is significant because it expands the scope of self‑disclosure beyond the formerly narrow “knowledge” requirement, offering broader compliance options for hospitals, insurers, and biomedical suppliers. Firms with healthcare clients should assess whether their practices meet the pilot’s qualification criteria (e.g., financial threshold, compliance quality), document disclosure efforts carefully, and engage with regulators early. The outcome of the pilot will influence future FCA enforcement guidance and could reshape best‑practice compliance strategies across the sector.

health-fcafalse-claims-acthhs-dojcompliance-pilotfederal-regulation
Read the original firm alert → Sunday, November 8, 2026

Stay ahead

Join the digest.

Each weekday's issue by email, through Substack. Or follow the RSS feed.